CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120. - Wikidata - wikimedia - TriplyDB

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

http://www.wikidata.org/entity/Q35023230

about

HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)High hopes for CB(2) receptors in neurogenesis.Effects of cannabinoids and their receptors on viral infections.Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.The role of human dopamine transporter in NeuroAIDS.Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV.

P2860

Q28392199-C58838D3-005A-4BDD-9FE0-CF579F290DBF Q36844731-06D54043-37A7-4A4B-966C-85984347EA28 Q37672037-C5ACA1F6-DADB-4AA1-BCA1-F99D121ED89B Q38217388-BA877AE4-7E8F-46B0-853D-20DA25814629 Q38274763-EA0F443E-2111-4EF7-8F55-7FA29C432497 Q38522557-ABC57C8D-2650-4D9B-9F9F-D0E0610DD21C Q40112882-88DC5E9A-18BD-42E2-B1B7-AF41E05A691C Q41922188-9D63CC11-989E-4BF6-9237-3AB618BCC2A5 Q47612809-51FBB275-4341-4015-806A-EEB5646DE266

P2860

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

http://www.wikidata.org/entity/Q35023230

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

@ast

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

@en

type

label

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

@ast

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

@en

prefLabel

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

@ast

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

@en

P1433

Q35023230-486B4E58-FC91-4B34-95A9-000CD757F391

P1476

Q35023230-917446A4-0CC7-44E2-B4EE-99F061C28CB1

P2093

Q35023230-0C2DD0F0-8A9E-43DF-8256-497A3C456D5E

Q35023230-5F75C3AB-3FD7-4890-BD7E-60BA8CDF60B8

Q35023230-D453A23A-A22E-40A1-A9C7-8C66B134B00F

P2860

Q35023230-002FF117-BFA7-44AF-9AB5-1F9E28C2D9C0

Q35023230-00403350-B319-4F77-8558-98B7389BEDDA

Q35023230-00A9E432-BF51-493B-923F-AA18D3060492

Q35023230-09CA1B0B-AB64-471F-8001-D07228B31D35

Q35023230-101BC93E-491A-4417-877E-092E7E68AADA

Q35023230-1133E3E4-67FD-41C0-B931-2BDA4F33D2EF

Q35023230-12479688-8EE5-4913-B140-902B239959A7

Q35023230-14E53ABC-1D30-4E24-9D09-A07897BE2B48

Q35023230-16481B7C-CD4E-4BD9-A548-4C896783319B

Q35023230-166801A6-4502-45A4-95C2-F1675A07417A

P304

Q35023230-6565CC49-C35E-4009-8777-5ADFAA70DB4F

P31

Q35023230-D2EF1054-E25E-48FA-9B92-5156F245F6C3

P356

Q35023230-48622A4F-DADA-4743-8EAC-D486666E159E

P407

Q35023230-BCDCC961-3297-4CD5-8635-81AA7D61E358

P433

Q35023230-E25E72AF-3122-46B8-A706-B6D308E37F4E

P478

Q35023230-F42FEB3A-56E0-4AAD-8E1A-9810B2F0B44E

P577

Q35023230-18745E43-8456-4337-963A-9411235C5573

P5875

Q35023230-23FB8442-227B-444B-A899-2A86BD224A1C

P698

Q35023230-09C7E114-1623-490D-9758-4E34D404473F

P921

Q35023230-9D286228-4D55-4FFE-9D1E-ACA71813B3D6

P932

Q35023230-37722CFF-A0A4-43ED-AD63-8E17732EAEAC

P356

JOURNAL.PONE.0077577

P1433

P1476

CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.

@en

P2093

R Bryan Rock

http://www.w3.org/2001/XMLSchema#string

Shuxian Hu

http://www.w3.org/2001/XMLSchema#string

Wen S Sheng

http://www.w3.org/2001/XMLSchema#string

P2860

kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression

Role of microglia in central nervous system infections

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor

Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia

Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis

Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions

P304

e77577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0077577

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258066642

http://www.w3.org/2001/XMLSchema#string

P698

24147028

http://www.w3.org/2001/XMLSchema#string

P921

P932

3798286

http://www.w3.org/2001/XMLSchema#string